Evidence map›Paper›PMID 40981992›Full record

ArticleEuropean radiology2026

A multi-class segmentation model of deep learning on contrast-enhanced computed tomography to segment and differentiate lipid-poor adrenal nodules: a dual-center study.

Xin Bai, Zhe Wu, Lin Lu, Hong Zhang, Huimin Zheng, Yan Zhang, Xiaopeng Liu, Zhong Zhang, Gumuyang Zhang, Daming Zhang and 2 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Xin Bai *Department of Radiology, State Key Laboratory of Complex Severe and Rare Disease, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
Zhe Wu *Department of Radiology, Fushun Central Hospital, Fushun, China.
Lin Lu *Department of Endocrinology, State Key Laboratory of Complex Severe and Rare Disease, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
Hong ZhangDepartment of Radiology, Hospital Peoples of Daye City, The Second Affiliated Hospital of Hubei Polytechnic University, Daye, China.
Huimin ZhengDepartment of Radiology, Longkou Second People's Hospital, Longkou, China.
Yan ZhangDepartment of Medical Imaging, Qujing Maternal and Children Healthcare Hospital, Qujing Maternal and Children Hospital, Qujing, China.
Xiaopeng LiuDepartment of Radiology, Linyi Traditional Chinese Medicine Hospital, Linyi, China.
Zhong ZhangWX Medical Technology Co. Ltd, Shenyang, China.
Gumuyang ZhangDepartment of Radiology, State Key Laboratory of Complex Severe and Rare Disease, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China. zhang_stacey@163.com.
Daming ZhangDepartment of Radiology, State Key Laboratory of Complex Severe and Rare Disease, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China. zhangdaming@pumch.cn.
Zhengyu JinDepartment of Radiology, State Key Laboratory of Complex Severe and Rare Disease, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China. jinzy@pumch.cn.
Hao SunDepartment of Radiology, State Key Laboratory of Complex Severe and Rare Disease, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China. sunhao_robert@126.com.

Funding

Beijing Municipal Natural Science Foundation L232133CAMS Innovation Fund for Medical Sciences (CIFMS) 2024-I2M-C&T-C-004National High-Level Hospital Clinical Research Funding 2022-PUMCH-A-033National High-Level Hospital Clinical Research Funding 2022-PUMCH-A-035National High-Level Hospital Clinical Research Funding 2022-PUMCH-B-068National High-Level Hospital Clinical Research Funding 2022-PUMCH-B-069National Key Research & Development Plan of China, Major Project of Prevention and Treatment for Common Diseases 2022YFC2505300, subproject 2022YFC2505304Peking Union Medical College Hospital Talent Cultivation Program (Category D) UHB11588
6 · The paper itself

Abstract

objectivesTo develop a deep-learning model for segmenting and classifying adrenal nodules as either lipid-poor adenoma (LPA) or nodular hyperplasia (NH) on contrast-enhanced computed tomography (CECT) images. MATERIALS AND

methodsThis retrospective dual-center study included 164 patients (median age 51.0 years; 93 females) with pathologically confirmed LPA or NH. The model was trained on 128 patients from the internal center and validated on 36 external cases. Radiologists annotated adrenal glands and nodules on 1-mm portal-venous phase CT images. We proposed Mamba-USeg, a novel state-space models (SSMs)-based multi-class segmentation method that performs simultaneous segmentation and classification. Performance was evaluated using the mean Dice similarity coefficient (mDSC) for segmentation and sensitivity/specificity for classification, with comparisons made against MultiResUNet and CPFNet.

resultsFrom per-slice segmentation, the model yielded an mDSC of 0.855 for the adrenal gland; for nodule segmentation, it achieved mDSCs of 0.869 (LPA) and 0.863 (NH), significantly outperforming two previous models-MultiResUNet (LPA, p < 0.001; NH, p = 0.014) and CPFNet (LPA, p = 0.003; NH, p = 0.023). Classification performance from per slice demonstrated sensitivity of 95.3% (95% confidence interval [CI] 91.3-96.6%) and specificity of 92.7% (95% CI: 91.9-93.6%) for LPA, and sensitivity of 94.2% (95% CI: 89.7-97.7%) and specificity of 91.5% (95% CI: 90.4-92.4%) for NH. The classification accuracy for patients from external sources was 91.7% (95% CI: 76.8-98.9%).

conclusionThe proposed multi-class segmentation model can accurately segment and differentiate between LPA and NH on CECT images, demonstrating superior performance to existing methods. KEY POINTS: Question Accurate differentiation between LPA and NH on imaging remains clinically challenging yet critically important for guiding appropriate treatment approaches. Findings Mamba-Useg, a multi-class segmentation model utilizing pixel-level analysis and majority voting strategies, can accurately segment and classify adrenal nodules as LPA or NH. Clinical relevance The proposed multi-class segmentation model can simultaneously segment and classify adrenal nodules, outperforming previous models in accuracy; it significantly aids clinical decision-making and thereby reduces unnecessary surgeries in adrenal hyperplasia patients.

Indexed as

AdenomaAdrenal Gland NeoplasmsDeep LearningTomography, X-Ray ComputedAdultAgedContrast MediaDiagnosis, DifferentialFemaleHumansMaleMiddle AgedRadiographic Image Interpretation, Computer-AssistedRetrospective StudiesSensitivity and SpecificityContrast MediaAdrenal gland diseasesAdrenocortical adenomaDeep learningTomography (X-ray computed)

Identifiers

PMID40981992

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.